Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Cardiff Oncology, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 112 | 1 | 110 | −1 |
| Shares | 25.2M | 88.9K | 27.2M | +2.13M (+8.5%) |
| Value | $51.9M | $183.1K | $76.6M | +$24.8M (+48.0%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Franklin Resources Inc | 1,205,803 | $3.39M | 0.00% |
| Candriam Luxembourg S.C.A. | 344,437 | $967.9K | 0.00% |
| Gsa Capital Partners LLP | 210,880 | $593.0K | 0.05% |
| Group One Trading, L.P. | 41,874 | $117.7K | 0.00% |
| Virtu Financial LLC | 38,479 | $108.0K | 0.00% |
| Golden State Equity Partners | 24,500 | $68.8K | 0.01% |
| SG Americas Securities, LLC | 15,798 | $44.0K | 0.00% |
| Skopos Labs, Inc. | 12,649 | $37.3K | 0.00% |
| R Squared Ltd | 12,701 | $35.7K | 0.02% |
| Tamar Securities, LLC | 11,495 | $32.3K | 0.00% |
| Capital Advisors Wealth Management, LLC | 10,500 | $29.5K | 0.00% |
| SageView Advisory Group, LLC | 6,490 | $18.2K | 0.00% |
| MetLife Investment Management | 6,230 | $17.5K | 0.00% |
| GAMMA Investing LLC | 746 | $2.10K | 0.00% |
| Motiv8 Investments LLC | 200 | $1.00K | 0.00% |
| Caitong International Asset Management Co., Ltd | 270 | $759 | 0.00% |
| Avion Wealth | 225 | $0 | 0.00% |
Sold out (18)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| National Bank of Canada | 208,700 | $429.9K |
| Renaissance Technologies LLC | 101,800 | $209.7K |
| AQR Capital Management LLC | 48,281 | $99.5K |
| Quadrature Capital Ltd | 31,493 | $64.7K |
| Commonwealth Equity Services, LLC | 28,465 | $59.0K |
| Readystate Asset Management LP | 21,024 | $43.3K |
| Two Sigma Securities, LLC | 16,528 | $34.0K |
| Brighton Jones LLC | 16,506 | $34.0K |
| Jeppson Wealth Management, LLC | 12,001 | $24.7K |
| Quarry LP | 11,135 | $22.9K |
| Simplex Trading, LLC | 9,053 | $18.0K |
| CIBC Private Wealth Group, LLC | 3,000 | $6.18K |
| Advisor Group Holdings, Inc. | 2,002 | $4.20K |
| Parallel Advisors, LLC | 1,000 | $2.06K |
| Vermillion & White Wealth Management Group, LLC | 500 | $1.03K |
| Optiver Holding B.V. | 498 | $1.03K |
| Nisa Investment Advisors, LLC | 209 | $431 |
| Colony Group, LLC | 5,185 | – |
Not filed for Q4 2025 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 88,903 | $183.1K |